Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.30p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.42
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 356,418
  • Market Cap: £9.56m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £34,160
Lisa Baderoon 583,963 £13,402
Tim Franklin 525,000 £12,049

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 66,161,974 £1,518,417
Luca & Associates AG 22,000,000 £504,900
Invesco Ltd 17,872,341 £410,170
Aviva Investors Global 11,285,180 £258,995
Alora Pharmaceuticals LLC 10,909,091 £250,364
M&G Investments 7,600,000 £174,420
Prudential plc 7,600,000 £174,420
Capital Income Builder 4,870,367 £111,775
Dr R Zimmer 4,551,553 £104,458
Odey Asset Management 3,433,319 £78,795
Rhone Trustees (Switzerland) SA 3,386,000 £77,709
Pictet Overseas Trust Corporation Limited 3,287,500 £75,448

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.30p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.42
52 Week Low 0.85
Volume 356,418
Shares Issued 416.44m
Market Cap £9.56m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.9% below the market average65.9% below the market average65.9% below the market average65.9% below the market average65.9% below the market average
20.75% below the sector average20.75% below the sector average20.75% below the sector average20.75% below the sector average20.75% below the sector average
Price Trend
28.37% below the market average28.37% below the market average28.37% below the market average28.37% below the market average28.37% below the market average
36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 18-Apr-2024

Time Volume / Share Price
12:04 60,934 @ 2.21p
11:15 90,909 @ 2.21p
09:20 63 @ 2.30p
09:09 134,360 @ 2.22p
08:56 16,046 @ 2.23p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page